Ligand Pharmaceuticals, Inc.

Share · US53220K2151 (OTC)

Overview

No Price

Closing Price OTC 04.11.2025: 0,006 USD

04.11.2025 15:07

Current Prices from Ligand Pharmaceuticals, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	LGNDZ	USD	04.11.2025 15:07	0,006 USD	0,00 USD

Company Profile for Ligand Pharmaceuticals, Inc. Share

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Get up to date insights from finAgent about Ligand Pharmaceuticals, Inc.

Company Data

Name Ligand Pharmaceuticals, Inc.

Company Ligand Pharmaceuticals, Inc.

Website https://www.ligand.com

Primary Exchange

UTC

ISIN US53220K2151

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Todd C. Davis

Country United States of America

Currency USD

Employees 0,1 T

Address 555 Heritage Drive, Jupiter

Ticker Symbols

Name	Symbol
Over The Counter	LGNDZ

More Shares

Investors who hold Ligand Pharmaceuticals, Inc. also have the following shares in their portfolio:

GRANITE MASTER ISSUER PLC CLASS A5 FLTG RTE NTS 25/12/54 (REGS) Bond

TeamLease Services Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog